The Patient Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.
Stay Connected. Manage Your Care.
Access your health information anytime and anywhere, at home or on the go, with MyHealth.
- Message your clinic
- View your lab results
- Schedule your next appointment
- Pay your bill
The MyHealth mobile app from Stanford Health Care puts all your health information at your fingertips and makes managing your health care simple and quick.
Guest Services
24/7
We are available to assist you
whenever you need it. Give us a call at
650-498-3333 or
PHYSICIAN HELPLINE
Have a question? We're here to help! Call 1-866-742-4811
Monday - Friday, 8 a.m. - 5 p.m.
REFER A PATIENT
Fax 650-320-9443
Track your patients' progress and communicate with Stanford providers conveniently and securely.
![](/was/20151211033644im_/https://stanfordhealthcare.org/content/dam/SHC/doctors-medicalstaff/d/diehn-maximilian-md.jpg/_jcr_content/renditions/cq5dam.thumbnail.319.319.png.transform/221x221/q82/image.png)
Maximilian Diehn, MD, PhD
Radiation oncologist
Professional Education
- Residency: Stanford Hospital and Clinics - Radiation Oncology (2009) CA
- Internship: Stanford University School of Medicine (2005) CA
- Board Certification: Radiation Oncology, American Board of Radiology (2010)
- Medical Education: Stanford University (2004) CA
- MD, Stanford University (2004)
- PhD, Stanford University, Biophysics (2004)
- AB, Harvard College, Biochemical Sciences (1997)
Honors & Awards
- Thomas Temple Hoopes Prize for outstanding senior thesis, Harvard University (1997)
- Medical Scientist Training Program, Stanford University (1997-2004)
- Franklin G. Ebaugh, Jr. Award for Research, Department of Medicine, Stanford University (2005)
- Annual Meeting Basic Science Travel Grant Award, American Society for Therapeutic Radiology and Oncology (ASTRO) (2006)
- Holman Research Pathway, American Board of Radiology (ABR) (2006-2009)
- Roentgen Resident/Fellow Research Award, Radiological Society of North America (RSNA) (2008)
- ASTRO Residents in Radiation Oncology Research Seed Grant, American Society for Therapeutic Radiology and Oncology (ASTRO) (2006-2008)
- RSNA Research Resident/Fellow Grant, Radiological Society of North America (RSNA) (2007-2009)
- Malcolm A. Bagshaw Award, Stanford University (2009)
- Donald E. and Delia B. Baxter Foundation Faculty Scholar Award, Donald E. and Delia B. Baxter Foundation (2011-2012)
- Henry S. Kaplan Memorial Prize for Teaching, Stanford University (2012)
- Sidney Kimmel Scholar Award, Sidney Kimmel Foundation (2010-2013)
- Edward Mallinckrodt, Jr. Foundation Grant, Edward Mallinckrodt, Jr. Foundation (2010-2014)
- Doris Duke Clinical Scientist Development Award, Doris Duke Charitable Foundation (2010-2014)
- Lung Cancer Research Program Promising Clinician Research Award, Department of Defense (2012-2014)
- Walter H. Coulter Translational Research Grant, Walter H. Coulter Foundation (2013-2014)
- V Foundation Scholar Grant, V Foundation (2013-2015)
- NIH Director's New Innovator Award, National Institute of Health (2013-2018)
Administrative Appointments
- Cancer Biology Graduate Program Admissions Committee, Stanford University (2012 - Present)
- Stem Cell Biology & Regenerative Medicine Graduate Program Admissions Committee, Stanford University (2013 - Present)
- Medical Scientist Training Program (MSTP) Admissions Committee, Stanford University (2011 - Present)
Publications
-
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. Cw., & Diehn, M. (2014). An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. NATURE MEDICINE, 20(5), 552-558. -
Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation
Lee, C. Y.-F., Lin, Y., Bratman, S. V., Feng, W., Kuo, A. H., & Diehn, M. (2014). Neuregulin Autocrine Signaling Promotes Self-Renewal of Breast Tumor-Initiating Cells by Triggering HER2/HER3 Activation. CANCER RESEARCH, 74(1), 341-352. -
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., & Clarke, M. F. (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. NATURE, 458(7239), 780-U123. -
Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors.
Harris, J. P., Chang-Halpenny, C. N., Maxim, P. G., Quon, A., Graves, E. E., & Loo, B. W. (2015). Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors. Clinical lung cancer, 16(6), 475-485.
-
Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.
Chaudhuri, A. A., Binkley, M. S., Osmundson, E. C., Alizadeh, A. A., & Diehn, M. (2015). Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Seminars in radiation oncology, 25(4), 305-312.
-
Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
Gentles, A. J., Bratman, S. V., Lee, L. J., Harris, J. P., Feng, W., & Diehn, M. (2015). Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute, 107(10).
-
Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial
Westover, K. D., Loo, B. W., Gerber, D. E., Iyengar, P., Choy, H., & Timmerman, R. (2015). Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 93(1), 72-81.
-
Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D
Jeong, Y., Swami, S., Krishnan, A. V., Williams, J. D., Martin, S., & Diehn, M. (2015). Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D. MOLECULAR CANCER THERAPEUTICS, 14(8), 1951-1961.
-
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., & Alizadeh, A. A. (2015). The prognostic landscape of genes and infiltrating immune cells across human cancers. NATURE MEDICINE, 21(8), 938-945.
-
Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
Binkley, M. S., Trakul, N., Jacobs, L. R., von Eyben, R., Quynh-Thu Le, Q. T., & Diehn, M. (2015). Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(5), 1044-1052.
-
Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
Chaudhuri, A. A., Tang, C., Binkley, M. S., Jin, M., Wynne, J. F., & Diehn, M. (2015). Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. LUNG CANCER, 89(1), 50-56.
-
Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy
King, M. T., Maxim, P. G., Diehn, M., Loo, B. W., & Xing, L. (2015). Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(3), 683-690.
-
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
Kurtz, D. M., Green, M. R., Bratman, S. V., Scherer, F., Liu, C. L., & Alizadeh, A. A. (2015). Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. BLOOD, 125(24), 3679-3687.
-
TU-AB-201-06: Evaluation of Electromagnetically Guided High- Dose Rate Brachytherapy for Ablative Treatment of Lung Metastases.
Pinkham, D. W., Shultz, D., Loo, B. W., Sung, A., Diehn, M., & Fahimian, B. P. (2015). TU-AB-201-06: Evaluation of Electromagnetically Guided High- Dose Rate Brachytherapy for Ablative Treatment of Lung Metastases. Medical physics, 42(6), 3595-?.
-
Robust enumeration of cell subsets from tissue expression profiles.
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., & Alizadeh, A. A. (2015). Robust enumeration of cell subsets from tissue expression profiles. Nature methods, 12(5), 453-457.
-
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., & Alizadeh, A. A. (2015). Robust enumeration of cell subsets from tissue expression profiles. NATURE METHODS, 12(5), 453-?.
-
Noninvasive pulmonary nodule elastometry by CT and deformable image registration
Negandar, M., Fasola, C. E., Yu, A. S., von Eyben, R., Yamamoto, T., & Maxim, P. G. (2015). Noninvasive pulmonary nodule elastometry by CT and deformable image registration. RADIOTHERAPY AND ONCOLOGY, 115(1), 35-40.
-
To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
Shultz, D. B., Diehn, M., & Loo, B. W. (2015). To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer. SEMINARS IN RADIATION ONCOLOGY, 25(2), 78-86.
-
FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution
Newman, A. M., Bratman, S. V., Stehr, H., Lee, L. J., Liu, C. L., & Alizadeh, A. A. (2014). FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. BIOINFORMATICS, 30(23), 3390-3393.
-
Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response
Kuo, P., Bratman, S. V., Shultz, D. B., von Eyben, R., Chan, C., & Quynh-Thu Le, Q. T. (2014). Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response. CLINICAL CANCER RESEARCH, 20(21), 5558-5569.
-
Pulmonary Ventilation Imaging Based on 4-Dimensional Computed Tomography: Comparison With Pulmonary Function Tests and SPECT Ventilation Images
Yamamoto, T., Kabus, S., Lorenz, C., Mittra, E., Hong, J. C., & Keall, P. J. (2014). Pulmonary Ventilation Imaging Based on 4-Dimensional Computed Tomography: Comparison With Pulmonary Function Tests and SPECT Ventilation Images. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(2), 414-422.
-
Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema
Binkley, M. S., Shrager, J. B., Leung, A. N., Popat, R., Trakul, N., & Loo, B. W. (2014). Lung Volume Reduction After Stereotactic Ablative Radiation Therapy of Lung Tumors: Potential Application to Emphysema. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90(1), 216-223.
-
Neurotrophic factor GDNF promotes survival of salivary stem cells
Xiao, N., Lin, Y., Cao, H., Sirjani, D., Giaccia, A. J., & Quynh-Thu Le, Q. T. (2014). Neurotrophic factor GDNF promotes survival of salivary stem cells. JOURNAL OF CLINICAL INVESTIGATION, 124(8), 3364-3377.
-
Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest.
Shultz, D. B., Trakul, N., Maxim, P. G., Diehn, M., & Loo, B. W. (2014). Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest. Practical radiation oncology, 4(4), 272-278.
-
Targeting Unique Metabolic Properties of Breast Tumor Initiating Cells
Feng, W., Gentles, A., Nair, R. V., Huang, M., Lin, Y., & Diehn, M. (2014). Targeting Unique Metabolic Properties of Breast Tumor Initiating Cells. STEM CELLS, 32(7), 1734-1745.
-
Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer.
Shultz, D. B., Trakul, N., Abelson, J. A., Murphy, J. D., Maxim, P. G., & Diehn, M. (2014). Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. Clinical lung cancer, 15(4), 294-301 e3.
-
Feasibility and Potential Utility of Multicomponent Exhaled Breath Analysis for Predicting Development of Radiation Pneumonitis After Stereotactic Ablative Radiotherapy
More, J. M., Eclov, N. Cw., Chung, M. P., Wynne, J. F., Shorter, J. H., & Diehn, M. (2014). Feasibility and Potential Utility of Multicomponent Exhaled Breath Analysis for Predicting Development of Radiation Pneumonitis After Stereotactic Ablative Radiotherapy. JOURNAL OF THORACIC ONCOLOGY, 9(7), 957-964.
-
The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy.
Shultz, D. B., Jang, S. S., Hanlon, A. L., Diehn, M., Loo, B. W., & Maxim, P. G. (2014). The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy. Practical radiation oncology, 4(3), 192-197.
-
A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non-Small Cell Lung Cancer
Harris, J. P., Murphy, J. D., Hanlon, A. L., Quynh-Thu Le, Q. T., Loo, B. W., & Diehn, M. (2014). A Population-Based Comparative Effectiveness Study of Radiation Therapy Techniques in Stage III Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 88(4), 872-884.
-
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal
Zhou, B., Damrauer, J. S., Bailey, S. T., Hadzic, T., Jeong, Y., & Kim, W. Y. (2014). Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. JOURNAL OF CLINICAL INVESTIGATION, 124(2), 553-563.
-
Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation.
Jamshidi, N., Diehn, M., Bredel, M., & Kuo, M. D. (2014). Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Radiology, 270(1), 1-2.
-
Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy.
Li, R., Han, B., Meng, B., Maxim, P. G., Xing, L., & Loo, B. W. (2013). Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. International journal of radiation oncology, biology, physics, 87(5), 917-923.
-
4D CT lung ventilation images are affected by the 4D CT sorting method.
Yamamoto, T., Kabus, S., Lorenz, C., Johnston, E., Maxim, P. G., & Keall, P. J. (2013). 4D CT lung ventilation images are affected by the 4D CT sorting method. Medical physics, 40(10), 101907-?.
-
Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors.
Liu, M. B., Eclov, N. Cw., Trakul, N., Murphy, J., Diehn, M., & Loo, B. W. (2013). Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. Practical radiation oncology, 3(4), 294-300.
-
Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy.
Hong, J. C., Eclov, N. Cw., Yu, Y., Rao, A. K., Dieterich, S., & Maxim, P. G. (2013). Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. Journal of applied clinical medical physics , 14(2), 4046-?.
-
The Optimal Use of Radiotherapy in Small Cell Lung Cancer
Shultz, D. B., Grecula, J. C., Hayman, J., Diehn, M., & Loo, B. W. (2013). The Optimal Use of Radiotherapy in Small Cell Lung Cancer. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(1), 107-114.
-
Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy
Hong, J. C., Eclov, N. Cw., Yu, Y., Rao, A. K., Dieterich, S., & Maxim, P. G. (2013). Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 14(2), 77-89.
-
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy
Abelson, J. A., Murphy, J. D., Trakul, N., Bazan, J. G., Maxim, P. G., & Loo, B. W. (2012). Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. LUNG CANCER, 78(3), 219-224.
-
Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors
Trakul, N., Harris, J. P., Le, Q.-T., Hara, W. Y., Maxim, P. G., & Diehn, M. (2012). Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors. JOURNAL OF THORACIC ONCOLOGY, 7(9), 1462-1465.
-
Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors
Trakul, N., Chang, C. N., Harris, J., Chapman, C., Rao, A., & Diehn, M. (2012). Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84(1), 231-237.
-
Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images
Li, R., Mok, E., Chang, D. T., Daly, M., Loo, B. W., & Xing, L. (2012). Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 83(5), E709-E715.
-
What the Diagnostic Radiologist Needs to Know about Radiation Oncology
Terezakis, S. A., Heron, D. E., Lavigne, R. F., Diehn, M., & Loo, B. W. (2011). What the Diagnostic Radiologist Needs to Know about Radiation Oncology. RADIOLOGY, 261(1), 30-44.
-
HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL MARKERS FOR IMAGE-GUIDED STEREOTACTIC ABLATIVE RADIOTHERAPY OF PULMONARY TUMORS
Hong, J. C., Yu, Y., Rao, A. K., Ditererich, S., Maxim, P. G., & Loo, B. W. (2011). HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL MARKERS FOR IMAGE-GUIDED STEREOTACTIC ABLATIVE RADIOTHERAPY OF PULMONARY TUMORS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(1), 85-90.
-
Reducing 4D CT artifacts using optimized sorting based on anatomic similarity
Johnston, E., Diehn, M., Murphy, J. D., Loo, B. W., & Maxim, P. G. (2011). Reducing 4D CT artifacts using optimized sorting based on anatomic similarity. MEDICAL PHYSICS, 38(5), 2424-2429.
-
Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer
Kozak, M. M., Murphy, J. D., Schipper, M. L., Donington, J. S., Zhou, L., & Loo, B. W. (2011). Tumor Volume as a Potential Imaging-Based Risk-Stratification Factor in Trimodality Therapy for Locally Advanced Non-small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 6(5), 920-926.
-
The Myc Connection: ES Cells and Cancer
Rothenberg, M. E., Clarke, M. F., & Diehn, M. (2010). The Myc Connection: ES Cells and Cancer. CELL, 143(2), 184-186.
-
STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER
Brown, J. M., Diehn, M., & Loo, B. W. (2010). STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(2), 323-327.
-
Metastatic Cancer Stem Cells: An Opportunity for Improving Cancer Treatment?
Diehn, M., & Majeti, R. (2010). Metastatic Cancer Stem Cells: An Opportunity for Improving Cancer Treatment?. CELL STEM CELL, 6(6), 502-503.
-
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
Chan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., & Weissman, I. L. (2009). Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(33), 14016-14021.
-
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., & Clarke, M. F. (2009). Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells. CELL, 138(3), 592-603.
-
Therapeutic Implications of the Cancer Stem Cell Hypothesis
Diehn, M., Cho, R. W., & Clarke, M. F. (2009). Therapeutic Implications of the Cancer Stem Cell Hypothesis. SEMINARS IN RADIATION ONCOLOGY, 19(2), 78-86.
-
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
Diehn, M., Nardini, C., Wang, D. S., McGovern, S., Jayaraman, M., & Kuo, M. D. (2008). Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 105(13), 5213-5218.
-
Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors
Cho, R. W., Wang, X., Diehn, M., Shedden, K., Chen, G. Y., & Clarke, M. F. (2008). Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. STEM CELLS, 26(2), 364-371.
-
Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment
Liang, Y., Diehn, M., Bollen, A. W., Israel, M. A., & Gupta, N. (2008). Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment. JOURNAL OF NEURO-ONCOLOGY, 86(2), 133-141.
-
Cancer stem cells and radiotherapy: New insights into tumor radioresistance
Diehn, M., & Clarke, M. F. (2006). Cancer stem cells and radiotherapy: New insights into tumor radioresistance. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 98(24), 1755-1757.
-
Cell-type specific gene expression profiles of leukocytes in human peripheral blood
Palmer, C., Diehn, M., Alizadeh, A. A., & Brown, P. O. (2006). Cell-type specific gene expression profiles of leukocytes in human peripheral blood. BMC GENOMICS, 7.
-
Genome-scale identification of membrane-associated human mRNAs
Diehn, M., Bhattacharya, R., Botstein, D., & Brown, P. O. (2006). Genome-scale identification of membrane-associated human mRNAs. PLOS GENETICS, 2(1), 39-50.
-
Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme
Liang, Y., Diehn, M., Watson, N., Bollen, A. W., Aldape, K. D., & Israel, M. A. (2005). Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 102(16), 5814-5819.
-
Differential gene expression in anatomical compartments of the human eye
Diehn, J. J., Diehn, M., Marmor, M. F., & Brown, P. O. (2005). Differential gene expression in anatomical compartments of the human eye. GENOME BIOLOGY, 6(9).
-
A method for detecting and correcting feature misidentification on expression microarrays
Tu, I. P., Schaner, M., Diehn, M., Sikic, B. I., Brown, P. O., & Fero, M. J. (2004). A method for detecting and correcting feature misidentification on expression microarrays. BMC GENOMICS, 5.
-
Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway
Piedras-Renteria, E. S., Pyle, J. L., Diehn, M., Glickfeld, L. L., Harata, N. C., & Tsien, R. W. (2004). Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 101(10), 3609-3614.
-
Gene expression patterns in ovarian carcinomas
Schaner, M. E., Ross, D. T., Ciaravino, G., Sorlie, T., Troyanskaya, O., & Sikic, B. I. (2003). Gene expression patterns in ovarian carcinomas. MOLECULAR BIOLOGY OF THE CELL, 14(11), 4376-4386.
-
T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression
Roose, J. P., Diehn, M., Tomlinson, M. G., Lin, J., Alizadeh, A. A., & Weiss, A. (2003). T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLOS BIOLOGY, 1(2), 271-287.
-
T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression.
Roose, J. P., Diehn, M., Tomlinson, M. G., Lin, J., Alizadeh, A. A., & Weiss, A. (2003). T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLoS biology, 1(2), E53-?.
-
Individuality and variation in gene expression patterns in human blood
Whitney, A. R., Diehn, M., Popper, S. J., Alizadeh, A. A., Boldrick, J. C., & Brown, P. O. (2003). Individuality and variation in gene expression patterns in human blood. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 100(4), 1896-1901.
-
SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data
Diehn, M., Sherlock, G., Binkley, G., Jin, H., Matese, J. C., & Alizadeh, A. A. (2003). SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. NUCLEIC ACIDS RESEARCH, 31(1), 219-223.
-
Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation
Diehn, M., Alizadeh, A. A., Rando, O. J., Liu, C. L., Stankunas, K., & Brown, P. O. (2002). Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(18), 11796-11801.
-
Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes
Lossos, I. S., Alizadeh, A. A., Diehn, M., Warnke, R., Thorstenson, Y., & Levy, R. (2002). Transformation of follicular lymphoma to diffuse large-cell lymphoma: Alternative patterns with increased or decreased expression of c-myc and its regulated genes. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(13), 8886-8891.
-
Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11.
Sayama, K., Diehn, M., Matsuda, K., Lunderius, C., Tsai, M., & Galli, S. J. (2002). Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. BMC immunology, 3, 5-?.
-
In vivo regulation of human skeletal muscle gene expression by thyroid hormone
Clement, K., Viguerie, N., Diehn, M., Alizadeh, A., Barbe, P., & Langin, D. (2002). In vivo regulation of human skeletal muscle gene expression by thyroid hormone. GENOME RESEARCH, 12(2), 281-291.
-
Stereotyped and specific gene expression programs in human innate immune responses to bacteria
Boldrick, J. C., Alizadeh, A. A., Diehn, M., Dudoit, S., Liu, C. L., & Relman, D. A. (2002). Stereotyped and specific gene expression programs in human innate immune responses to bacteria. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(2), 972-977.
-
Transcriptional programs activated by exposure of human prostate cancer cells to androgen
DePrimo, S. E., Diehn, M., Nelson, J. B., Reiter, R. E., Matese, J., & Brooks, J. D. (2002). Transcriptional programs activated by exposure of human prostate cancer cells to androgen. GENOME BIOLOGY, 3(7).
-
Comparing functional genomic datasets: lessons from DNA. microarray analyses of host-pathogen interactions
Diehn, M., & Relman, D. A. (2001). Comparing functional genomic datasets: lessons from DNA. microarray analyses of host-pathogen interactions. CURRENT OPINION IN MICROBIOLOGY, 4(1), 95-101.
-
Examining the living genome in health and disease with DNA microarrays
Diehn, M., Alizadeh, A. A., & Brown, P. O. (2000). Examining the living genome in health and disease with DNA microarrays. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 283(17), 2298-2299.
-
Large-scale identification of secreted and membrane-associated gene products using DNA microarrays
Diehn, M., Eisen, M. B., Botstein, D., & Brown, P. O. (2000). Large-scale identification of secreted and membrane-associated gene products using DNA microarrays. NATURE GENETICS, 25(1), 58-62.
-
Degradation of proteins from the ER of S-cerevisiae requires an intact unfolded protein response pathway
Casagrande, R., Stern, P., Diehn, M., Shamu, C., Osario, M., & Ploegh, H. (2000). Degradation of proteins from the ER of S-cerevisiae requires an intact unfolded protein response pathway. MOLECULAR CELL, 5(4), 729-735.
-
Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade
Bunnell, S. C., Diehn, M., Yaffe, M. B., Findell, P. R., Cantley, L. C., & Berg, L. J. (2000). Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(3), 2219-2230.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Patient Comments
Patients comments are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
SHC Patient, Jul 2014
A very good experience.
SHC Patient, Dec 2013
Thorough and to the point. I ask for truth and was given it.
SHC Patient, Jul 2014
A very good experience.
SHC Patient, Dec 2013
Thorough and to the point. I ask for truth and was given it.